Detalhe da pesquisa
1.
Inhibition of ALK2 with bicyclic pyridyllactams.
Bioorg Med Chem Lett
; 55: 128452, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780900
2.
Catalytic asymmetric synthesis of 8-oxabicyclooctanes by intermolecular [5+2] pyrylium cycloadditions.
Angew Chem Int Ed Engl
; 53(23): 5912-6, 2014 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24782332
3.
Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach.
ACS Med Chem Lett
; 14(3): 312-318, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923909
4.
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2.
ACS Med Chem Lett
; 13(7): 1159-1164, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35859885
5.
Discovery of Potent and Selective Inhibitors of Wild-Type and Gatekeeper Mutant Fibroblast Growth Factor Receptor (FGFR) 2/3.
J Med Chem
; 65(22): 15433-15442, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356320
6.
Dual catalysis in enantioselective oxidopyrylium-based [5 + 2] cycloadditions.
J Am Chem Soc
; 133(37): 14578-81, 2011 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21848300
7.
Solid phase synthesis of hydrogen bond surrogate derived alpha-helices: resolving the case of a difficult amide coupling.
Org Biomol Chem
; 8(8): 1773-6, 2010 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-20449477
8.
Rhodium(III)-Catalyzed Imidoyl C-H Activation for Annulations to Azolopyrimidines.
Org Lett
; 20(8): 2464-2467, 2018 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29582661
9.
X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.
J Med Chem
; 60(22): 9299-9319, 2017 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116812
10.
A Simple Primary Amine Catalyst for Enantioselective α-Hydroxylations and α-Fluorinations of Branched Aldehydes.
Org Lett
; 17(11): 2772-5, 2015 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25952578